NCT04262648View on ClinicalTrials.gov

Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

May 16, 2022

Study Completion Date

May 16, 2022

Conditions
Infantile ColicConstipationInfantile DiarrheaGastro Esophageal Reflux
Interventions
DIETARY_SUPPLEMENT

Lactobacillus Reuteri

Lactobacillus Reuteri NCIMB 30351

DIETARY_SUPPLEMENT

Placebo

Sunflower oil

Trial Locations (2)

Unknown

Children's City Clinical Hospital named after Bashlyaeva, Healthcare department of Moscow city, Moscow

"Medical Center St. Andrew's Hospitals - NEBOLIT", Moscow

All Listed Sponsors
lead

NovoNatum Ltd

INDUSTRY

NCT04262648 - Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns | Biotech Hunter | Biotech Hunter